Elimination of lipaemic interference by high-speed centrifugation.
high-speed centrifugation
lipaemia
lipaemic index
Journal
Biochemia medica
ISSN: 1846-7482
Titre abrégé: Biochem Med (Zagreb)
Pays: Croatia
ID NLM: 9610305
Informations de publication
Date de publication:
15 Feb 2023
15 Feb 2023
Historique:
received:
11
07
2022
accepted:
02
10
2022
entrez:
11
1
2023
pubmed:
12
1
2023
medline:
13
1
2023
Statut:
ppublish
Résumé
In order to deliver high quality results, detection and elimination of possible analytical interferences, such as lipaemia, is crucial. The aim of this study is to evaluate the efficacy of high-speed centrifugation in eliminating lipaemic interference and to define own lipaemic index (LI) for the studied biochemical analytes. Evaluated analytes were: albumin, alkaline phosphatase, alanine-aminotransferase (ALT), aspartate-aminotransferase (AST), calcium, creatinine, gamma-glutamyltransferase (GGT), glucose, phosphates, total proteins, urea and total bilirubin. Those analytes and LIs have been analysed in duplicate in the Roche Diagnostics-c8000 analyser in samples centrifuged at 3000 rpm/10 minutes in the SL16 (Thermo Scientific, Waltham, USA) centrifuge and according to an own high-speed centrifugation protocol (12,900 rpm/15 minutes) in the MicroCL17R (Thermo Scientific, Waltham, USA) centrifuge. Lipaemia has been measured in each sample. The efficiency of high-speed centrifugation is verified by the Wilcoxon test (P < 0.05). In cases where significant differences are observed, our own LI is calculated. For ALT and AST, it is verified by McNemar test (P < 0.05 There were statistically significant differences in analyte concentration before and after high-speed centrifugation for: albumin, creatinine, GGT, glucose, phosphates, urea and total bilirrubin. Own LI is calculated. McNemar test shows statistically significant diferences in the proportion of delivered results before and after high-speed centrifugation in ALT, AST and creatinine. This study confirms the efficacy of high-speed centrifugation protocol for all the considered analytes, excepting calcium, alkaline phosphatase and total proteins.
Identifiants
pubmed: 36627977
doi: 10.11613/BM.2023.010703
pii: bm-33-1-010703
pmc: PMC9807237
doi:
Substances chimiques
Calcium
SY7Q814VUP
Creatinine
AYI8EX34EU
Alkaline Phosphatase
EC 3.1.3.1
Glucose
IY9XDZ35W2
Alanine Transaminase
EC 2.6.1.2
Albumins
0
Phosphates
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
010703Informations de copyright
Croatian Society of Medical Biochemistry and Laboratory Medicine.
Déclaration de conflit d'intérêts
Potential conflict of interest None declared.
Références
Ann Lab Med. 2018 Nov;38(6):518-523
pubmed: 30027694
Clin Chim Acta. 2013 Nov 15;426:33-40
pubmed: 23981842
Clin Biochem. 2014 Mar;47(4-5):309-14
pubmed: 24434304
Biochem Med (Zagreb). 2011;21(1):86-92
pubmed: 22141212
Biochem Med (Zagreb). 2014 Feb 15;24(1):57-67
pubmed: 24627715